Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The rebel angel: mutant p53 as the driving oncogene in breast cancer.

Carcinogenesis - 1 Nov 2012

Walerych Dawid, Napoli Marco, Collavin Licio, Del Sal Giannino

Abstract excerpt

Breast cancer is the most frequent invasive tumor diagnosed in women, causing over 400 000 deaths yearly worldwide. Like other tumors, it is a disease with a complex, heterogeneous genetic and biochemical background. No single genomic or metabolic condition can be regarded as decisive for its formation and progression. However, a few key players can be pointed out and among them is the TP53 tumor suppressor gene,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Oncogenes
Share to Breast Neoplasms
Share to Cancer Genomics and Diagnostics

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cancer-related Molecular Pathways

Share to Epigenetics and DNA Methylation

Share to Genes, p53

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 22822097
DOI: 10.1093/carcin/bgs232
PMCID: PMC3483014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The rebel angel: mutant p53 as the driving oncogene in breast cancer.PMID 22822097Read ↗

Targeting mutant p53: a key player in breast cancer pathogenesis and beyond.Semantic proximity Read ↗

Targeting mutant p53 in cancer: a long road to precision therapySemantic proximity Read ↗

Mutant p53: One, No One, and One Hundred ThousandSemantic proximity Read ↗

Role of p53 in breast cancer progression: An insight into p53 targeted therapy.Semantic proximity Read ↗

Mutant p53: evolving perspectives.Semantic proximity Read ↗

Recent advances in p53 research: an interdisciplinary perspective.Semantic proximity Read ↗

Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others.Semantic proximity Read ↗

Targeting mutant p53 in cancer: from mechanistic insights to therapeutic strategies.Semantic proximity Read ↗

Mutant p53: the loaded gun.Semantic proximity Read ↗

Dysregulation of P53 in breast cancer: Causative factors and treatment strategies.Semantic proximity Read ↗

TP53: an oncogene in disguise.Semantic proximity Read ↗

p53 in breast cancer: mutation and countermeasures.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.